Literature DB >> 29695690

[Overexpression of microRNAs miR-9, -98, and -199 Correlates with the Downregulation of HK2 Expression in Colorectal Cancer].

A V Snezhkina1, G S Krasnov1, S O Zhikrivetskaya1, I Y Karpova1, M S Fedorova1, K M Nyushko2, M M Belyakov2, N V Gnuchev3, D V Sidorov2, B Y Alekseev2, N V Melnikova1, A V Kudryavtseva1,2,4.   

Abstract

Glycolysis activation is one of the main features of energy metabolism in cancer cells that is associated with the increase in glycolytic enzyme synthesis, primarily, hexokinases (HKs), in many types of tumors. Conversely, in colorectal cancer (CRC) the decrease in the expression of HK2 gene, which encodes one of the key rate-limiting enzyme of glycolysis, was revealed, thus, the study of the mechanisms of its inhibition in CRC is of particular interest. To search for potential microRNAs, inhibiting the expression of HK2 in CRC, we have performed the analysis of data from "The Cancer Genome Atlas" (TCGA) and five microRNA-mRNA target interaction databases (TargetScan, DIANA microT, mirSVR (miRanda), PicTar, and miRTarBase) using original CrossHub software. Seven microRNAs containing binding site on mRNA HK2, which expression is negatively correlated with HK2 expression, were selected for further analysis. The expression levels of these microRNAs and mRNA HK2 were estimated by quantitative PCR on a set of CRC samples. It has been shown, that the expression of three microRNAs (miR-9-5p, -98-5p, and -199-5p) was increased and correlated negatively with mRNA level of HK2 gene. Thus, downregulation of HK2 gene may be caused by its negative regulation through microRNAs miR-9-5p, -98-5p, and -199-5p.

Entities:  

Keywords:  HK2; colorectal cancer; glycolysis; microRNA; qPCR

Mesh:

Substances:

Year:  2018        PMID: 29695690     DOI: 10.7868/S0026898418020052

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  5 in total

1.  Mutational load in carotid body tumor.

Authors:  Anna V Kudryavtseva; Elena N Lukyanova; Dmitry V Kalinin; Andrew R Zaretsky; Anatoly V Pokrovsky; Alexander L Golovyuk; Maria S Fedorova; Elena A Pudova; Sergey L Kharitonov; Vladislav S Pavlov; Anastasiya A Kobelyatskaya; Nataliya V Melnikova; Alexey A Dmitriev; Andrey P Polyakov; Boris Y Alekseev; Marina V Kiseleva; Andrey D Kaprin; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

2.  A preliminary study of microRNA expression in different types of primary melanoma.

Authors:  Ioana Gencia; Flavia Baderca; Stefania Avram; Armand Gogulescu; Anca Marcu; Edward Seclaman; Catalin Marian; Caius Solovan
Journal:  Bosn J Basic Med Sci       Date:  2020-05-01       Impact factor: 3.363

3.  miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.

Authors:  Song Gao; Jianchao Wang; Shujian Tian; Jianping Luo
Journal:  Int J Oncol       Date:  2019-04-12       Impact factor: 5.650

4.  Differentially Expressed Genes Associated With Prognosis in Locally Advanced Lymph Node-Negative Prostate Cancer.

Authors:  Elena A Pudova; Elena N Lukyanova; Kirill M Nyushko; Dmitry S Mikhaylenko; Andrew R Zaretsky; Anastasiya V Snezhkina; Maria V Savvateeva; Anastasiya A Kobelyatskaya; Nataliya V Melnikova; Nadezhda N Volchenko; Gennady D Efremov; Kseniya M Klimina; Anastasiya A Belova; Marina V Kiseleva; Andrey D Kaprin; Boris Y Alekseev; George S Krasnov; Anna V Kudryavtseva
Journal:  Front Genet       Date:  2019-08-09       Impact factor: 4.599

5.  Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients.

Authors:  Shaian Tavakolian; Hossein Goudarzi; Ebrahim Faghihloo
Journal:  BMC Res Notes       Date:  2020-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.